My feeling on that is that we need to publish the ILADS guidelines because they tell physicians that patient preference is important: here's the evidence; how long do we want to treat for; what are the options. Physicians can look at the research and at the patient preference for treatment. These evidence-based guidelines are a very valuable tool for physicians to have access to.
The second thing I mentioned was developing a cohort of physicians where people like Ralph and me and the very small group of us who treat chronic infections can train a larger cohort to spread that knowledge further in Canada.